RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
LEUKEMIA
Collezione ASL Asti

Items : 4

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. in Leukemia / Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.

2020
ASL Asti

Barbui T; Ghirardi A; Vannucchi AM; Marchetti M; De Stefano V;

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. in Leukemia / Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.

2019
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Alvarez-Larran A; Finazzi G; Vannucchi AM; Griesshammer M; Recasens V; Marchetti M; Cacciola R; McMullin MF; Tieghi A; Carli G; Beggiato E; Benevolo G; Fox ML; Lunghi F; Angona A; Wille K; Perez-Encinas M; Gomez M; Erez D; Palova M; Bertolotti L; Elli EM; Guglielmelli P; Casetti IC; Stephenson C; Patriarca A; Rumi E; Bonifacio M; Scaffidi L; et alii...

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.

2018
ASL Asti

Barbui T; Tefferi A; Vannucchi AM; Passamonti F; Silver RT; Hoffman R; Verstovsek S; Mesa R; Kiladjian JJ; Hehlmann R; Reiter A; Cervantes F; Harrison C; Mc Mullin MF; Hasselbalch HC; Koschmieder S; Marchetti M; Bacigalupo A; Finazzi G; Kroeger N; Griesshammer M; Birgegard G; Barosi G;

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.

2017
ASL Asti

Marchetti M; Barosi G; Cervantes F; Birgegård G; Griesshammer M; Harrison C; Hehlmann R; Kiladjian JJ; Kröger N; McMullin MF; Passamonti F; Vannucchi A; Barbui T;